Cardlytics Inc (NASDAQ:CDLX) has a beta value of 1.32 and has seen 2.29 million shares traded in the last trading session. The company, currently valued at $101.64M, closed the last trade at $2.00 per share which meant it lost -$0.24 on the day or -10.71% during that session. The CDLX stock price is -926.0% off its 52-week high price of $20.52 and -11.5% below the 52-week low of $2.23.
The consensus among analysts is that Cardlytics Inc (CDLX) is Buy stock at the moment, with a recommendation rating of 3.17. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.2.
Cardlytics Inc (NASDAQ:CDLX) trade information
Sporting -10.71% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CDLX stock price touched $2.00 or saw a rise of 25.93%. Year-to-date, Cardlytics Inc shares have moved -46.09%, while the 5-day performance has seen it change -23.95%. Over the past 30 days, the shares of Cardlytics Inc (NASDAQ:CDLX) have changed -35.90%.
Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 50.0% from current levels. The projected low price target is $4.0 while the price target rests at a high of $4.0. In that case, then, we find that the current price level is -100.0% off the targeted high while a plunge would see the stock gain -100.0% from current levels.
Cardlytics Inc (CDLX) estimates and forecasts
The company’s shares have lost -42.69% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -13.35%.
6 analysts offering their estimates for the company have set an average revenue estimate of 63.63M for the current quarter. 5 have an estimated revenue figure of 61.26M for the next ending quarter. Year-ago sales stood 89.17M and 67.61M respectively for this quarter and the next, and analysts expect sales will shrink by -28.64% for the current quarter and -13.35% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -5.75% over the past 5 years. Earnings growth for 2025 is a modest -10.30% while over the next 5 years, the company’s earnings are expected to increase by 27.95%.
CDLX Dividends
Cardlytics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cardlytics Inc (NASDAQ:CDLX)’s Major holders
The top two institutional holders are CAS INVESTMENT PARTNERS, LLC with over 6.46 million shares worth more than $53.08 million. As of 2024-06-30, CAS INVESTMENT PARTNERS, LLC held 13.1785% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 3.15 million shares as of 2024-06-30. The firm’s total holdings are worth over $25.88 million and represent 7.2876% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . As of Sep 30, 2024 , the former fund manager holds about 2.72% shares in the company for having 1.38 shares of worth $2.77 million while later fund manager owns 1.18 shares of worth $2.36 million as of Dec 31, 2024 , which makes it owner of about 2.32% of company’s outstanding stock.
